Pharmaceutical Grade 3,5-Difluoropyridine-2,6-Diamine: COA Quality Assurance & Bulk Supply
- Process Chemists: Optimized synthesis route details impurity profiles and reaction yields for Delafloxacin intermediates.
- Sourcing Strategy: Factory-direct bulk price advantages ensure stable supply chains for tonnage quantities.
- Regulatory Compliance: Full COA verification and adherence to global export standards for pharmaceutical grade materials.
In the landscape of modern medicinal chemistry, the reliability of fluorinated heterocycles is paramount for developing next-generation antibacterial agents. 3,5-Difluoropyridine-2,6-diamine (CAS: 247069-27-8) serves as a critical Pyridine derivative in the production of fluoroquinolone antibiotics. For procurement officers and technical directors, securing a vendor capable of delivering consistent industrial purity alongside comprehensive documentation is not merely a preference but a regulatory necessity. This analysis details the technical specifications, quality assurance protocols, and supply chain advantages available through premier manufacturing channels.
Technical Specifications and Quality Parameters
Ensuring batch-to-batch consistency requires rigorous adherence to physical and chemical standards. The following table outlines the critical identity and purity parameters expected for commercial grade procurement. Deviations in melting point or assay values can significantly impact downstream reaction yields.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 247069-27-8 | Registry Verification |
| Molecular Formula | C5H5F2N3 | Elemental Analysis |
| Molecular Weight | 145.11 g/mol | Calculated |
| Appearance | White to Light Brown Solid | Visual Inspection |
| Purity (HPLC) | ≥ 98.0% / ≥ 99.0% | Area Normalization |
| Melting Point | ~160°C | DSC / Capillary |
| Storage Conditions | 2-8°C, Protect from Light | Stability Protocol |
Synthesis Route and Impurity Profiling for R&D
For process chemists evaluating this Fluorinated building block, understanding the manufacturing process is essential for risk assessment. The compound is typically obtained through the hydrolysis of specific protected derivatives. Controlling the reaction conditions during this step is vital to minimize the formation of defluorinated byproducts or incomplete hydrolysis intermediates.
High-performance liquid chromatography (HPLC) methods must be validated to detect trace impurities that could interfere with the subsequent synthesis of 1-(6-amino-3,5-difluoropyridin-2-yl)fluoroquinolone. A robust synthesis route ensures that the final 2,6-Diamino-3,5-difluoropyridine meets the strict requirements for antimycobacterial activity development. Manufacturers capable of providing detailed impurity profiles demonstrate a higher level of technical competency, reducing the burden on the buyer’s quality control laboratory.
Procurement Stability and Bulk Supply Chain
Transitioning from gram-scale research to commercial production requires a partner with proven capacity. Market data indicates significant price volatility for small-pack reagents; however, securing a stable supply through direct manufacturer contracts mitigates this risk. When sourcing high-purity 3,5-Difluoropyridine-2,6-diamine, buyers should prioritize vendors who offer tonnage quantities with guaranteed lead times.
NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier global manufacturer offering these technical advantages and bulk supply capabilities. By eliminating intermediaries, procurement teams can negotiate a competitive bulk price while ensuring that the material originates from a verified production line. This factory-direct model also simplifies the logistics of hazardous material transport, ensuring compliance with UN transport regulations (UN2811) and proper packaging integrity.
Regulatory Compliance and Executive Oversight
For executive stakeholders, the commercial viability of any API intermediate hinges on regulatory adherence. Sourcing pharmaceutical grade materials requires more than just a specification sheet; it demands a complete COA (Certificate of Analysis) and SDS (Safety Data Sheet) for every batch. Compliance with international standards such as REACH and TSCA is non-negotiable for export into European and North American markets.
Quality assurance protocols must extend beyond the final product to include raw material verification and process validation. A reliable global manufacturer will maintain ISO 9001 certified quality management systems, providing the audit trails necessary for regulatory filings. This level of documentation protects the supply chain from disruptions and ensures that the final drug product meets safety standards for patient use.
Conclusion and Next Steps
Securing a reliable source for critical intermediates like 3,5-Difluoropyridine-2,6-diamine is a strategic decision that impacts both R&D timelines and production costs. By prioritizing vendors with transparent manufacturing processes and robust quality assurance systems, organizations can safeguard their supply chains against variability.
To verify current inventory levels or request technical documentation, please contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. Partnering with NINGBO INNO PHARMCHEM CO.,LTD. ensures access to high-quality chemical intermediates backed by rigorous testing and global compliance standards.